Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2004 1
2013 1
2014 1
2015 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Real-life long-term omalizumab therapy in children with severe allergic asthma.
Deschildre A, Marguet C, Langlois C, Pin I, Rittié JL, Derelle J, Abou Taam R, Fayon M, Brouard J, Dubus JC, Siret D, Weiss L, Pouessel G, Beghin L, Just J. Deschildre A, et al. Among authors: derelle j. Eur Respir J. 2015 Sep;46(3):856-9. doi: 10.1183/09031936.00008115. Epub 2015 May 28. Eur Respir J. 2015. PMID: 26022964 Free article. No abstract available.
Long-term outcome of idiopathic pulmonary hemosiderosis in children.
Le Clainche L, Le Bourgeois M, Fauroux B, Forenza N, Dommergues JP, Desbois JC, Bellon G, Derelle J, Dutau G, Marguet C, Pin I, Tillie-Leblond I, Scheinmann P, De Blic J. Le Clainche L, et al. Among authors: derelle j. Medicine (Baltimore). 2000 Sep;79(5):318-26. doi: 10.1097/00005792-200009000-00005. Medicine (Baltimore). 2000. PMID: 11039080 Free article.
We retrospectively analyzed the long-term outcome of idiopathic pulmonary hemosiderosis (IPH) in 15 children. ...According to chest X-ray and pulmonary function test data, 4 patients had normal chest X-ray and no evidence of restrictive syndrome, 6 patients had an intersti …
We retrospectively analyzed the long-term outcome of idiopathic pulmonary hemosiderosis (IPH) in 15 children. ...According to chest X …
Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C, Destruys L, Grenet D, Bassinet L, Derelle J, Sermet-Gaudelus I, Thumerelle C, Prevotat A, Rosner V, Clement A, Corvol H. Perisson C, et al. Among authors: derelle j. Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10. Respir Med. 2017. PMID: 29173443 Free article.
The mainstay treatment consists of a combination of corticosteroids and antifungals. However, repeated or long-term corticosteroid therapies can lead to serious side effects. The monoclonal anti-IgE antibody, omalizumab, has demonstrated its efficacy in allergic asthma. .. …
The mainstay treatment consists of a combination of corticosteroids and antifungals. However, repeated or long-term corticosteroid th …
Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients.
Munck A, Malbezin S, Bloch J, Gerardin M, Lebourgeois M, Derelle J, Bremont F, Sermet I, Munck MR, Navarro J. Munck A, et al. Among authors: derelle j. Eur Respir J. 2004 Mar;23(3):430-4. doi: 10.1183/09031936.04.00052504. Eur Respir J. 2004. PMID: 15065834 Free article.
The mean functional time per device was 32 +/- 25 months. Long-term complications occurred with 188 devices (42%); they consisted mainly of occlusion (21%, requiring removal in 77%), infection (9.3%, requiring removal in 851%; septicaemia in 7.3%; rate 0.3 per 1,000 days, …
The mean functional time per device was 32 +/- 25 months. Long-term complications occurred with 188 devices (42%); they consisted mai …
[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M. Derelle J, et al. Arch Pediatr. 1998 Apr;5(4):371-7. doi: 10.1016/s0929-693x(98)80022-5. Arch Pediatr. 1998. PMID: 9759155 French.
This stabilisation is by itself a very encouraging result. Long-term comparative studies are needed to evaluate the benefits of dornase alfa in the treatment of respiratory complications of cystic fibrosis and specify the optimal modalities of its use. ...
This stabilisation is by itself a very encouraging result. Long-term comparative studies are needed to evaluate the benefits of dorna …